In addition, targeting NRF2 was demonstrated to reverse the radioresistance of NSCLC by inducing mitochondrial dysfunction and promoting ferritinophagy through the upregulation of PHKG2 expression [37]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.